Skip to content
‹ Back to IndustriesHealthcare

What Trust Means for Drones in the Highway in the Sky

Bringing together leaders, lawmakers and lawbreakers. Host Luke Fox explores how innovations in business and technology are redefining our trust in security measures.   Trust plays a huge role in technology and with the growing capabilities of drones for delivery. To understand the role of trust in managing the highway in the sky, The Trust Revolution host…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
What Trust Means for Drones in the Highway in the Sky

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

Bringing together leaders, lawmakers and lawbreakers. Host Luke Fox explores how innovations in business and technology are redefining our trust in security measures.

Trust plays a huge role in technology and with the growing capabilities of drones for delivery. To understand the role of trust in managing the highway in the sky, The Trust Revolution host Luke Fox spoke with Ken Stewart, President and CEO of NUAIR (Northeast UAS Airspace Integration Research Alliance).

“The idea is a commercial model for UTM that’s scalable and economically viable. We’re working on healthcare delivery as a focus. How can we use drones to do this safely and efficiently?” – Ken Stewart

Stewart has an impressive background, working in wireless telecom, cloud-based software, and federated platforms. Stewart shared how trust shaped his pre-NUAIR career. He worked on a third-party, independent clearinghouse for mobile carriers. “It was a trusted platform in the industry that was able to authenticate and authorize and eventually became big in fraud detection, too.”

Another critical role was working on democratizing the network spectrum on demand, which exposed him to working with the FTC. “We devised a way to share it in real-time, and that led to spectrum for autonomous systems.”

Stewart led a GE aviation company relating to remote IDs or license plates for drones. “There’s a lot to putting drones in the air, and we had to create a trust network with diverse groups that different objections,” he added.

A lot of information and data exchange occurs in spectrum usage, and a trusted partnership was difficult because not all users or their data had verification.

With NUAIR, Stewart now has a new vision for the commercialization of drone use cases. “We operate a test site for the industry to test applications. It’s flexible air space the FAA allows us to provide access,” he shared. Users gather data, test ops over people, and design concepts.

They also surveil a 50-mile traffic area, gathering important data to support the commercialization efforts of drone delivery. “The idea is a commercial model for UTM that’s scalable and economically viable. We’re working on healthcare delivery as a focus. How can we use drones to do this safely and efficiently?”

Catch Up On Previous Episodes of The Trust Revolution!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512